Skip to main content
. 2018 Jun 15;18(2):2043–2051. doi: 10.3892/mmr.2018.9178

Figure 2.

Figure 2.

YC-1 reduces inflammatory cellular infiltration in the ischemic brain. Relative to controls, 25 mg/kg YC-1 treated animals had reduced numbers of (A) iNOS, (B) MPO and (C) ED-1-immunopositive cells at 48 h post-insult. Scale bar=100 µm. Data are expressed as the mean ± standard deviation (n=5/group). *P<0.05 vs. control. YC-1, 3-(5-hydroxymethyl-2-furyl)-1-benzyl-indazole; iNOS, inducible nitric oxide synthase; MPO, myeloperoxidase.